AMPLIFIED MTD (MYCOBACTERIUM TUBERCULOSIS DIRECT) TEST

System, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex

FDA Premarket Approval P940034 S019

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Change in the amplification positive control used for quality control testing.

DeviceAMPLIFIED MTD (MYCOBACTERIUM TUBERCULOSIS DIRECT) TEST
Classification NameSystem, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex
Generic NameSystem, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex
ApplicantGEN-PROBE, INC.
Date Received2012-11-07
Decision Date2012-12-05
PMAP940034
SupplementS019
Product CodeMWA
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address GEN-PROBE, INC. 10210 Genetic Center Dr. san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P940034Original Filing
S019 2012-11-07 30-day Notice
S018 2010-03-31 30-day Notice
S017 2006-07-27 135 Review Track For 30-day Notice
S016 2004-09-21 30-day Notice
S015 2004-01-22 30-day Notice
S014
S013 2001-12-18 Special (immediate Track)
S012 2001-03-02 Normal 180 Day Track
S011 2000-10-25 Real-time Process
S010 1999-05-12 30-day Notice
S009 1998-10-19 Special (immediate Track)
S008 1998-09-04 Panel Track
S007 1998-08-17 Normal 180 Day Track
S006 1997-09-15 Normal 180 Day Track
S005 1997-07-02 Normal 180 Day Track
S004 1997-01-24 Normal 180 Day Track
S003 1996-06-17 Normal 180 Day Track
S002 1996-05-22 Special (immediate Track)
S001 1996-02-23 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
15420045500303 P940034 019

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.